Literature DB >> 19996288

MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1.

Mohit Sachdeva1, Yin-Yuan Mo.   

Abstract

MicroRNAs are important gene regulators that could play a profound role in tumorigenesis. Our previous studies indicate that miR-145 is a tumor suppressor capable of inhibiting tumor cell growth both in vitro and in vivo. In this study, we show that miR-145 exerts its function in a cell-specific manner. Although miR-145 inhibits cell growth in MCF-7 and HCT-116 cells, it has no significant effect on cell growth in metastatic breast cancer cell lines. However, miR-145 significantly suppresses cell invasion in these cells; in contrast, the antisense oligo against miR-145 increases cell invasion. miR-145 is also able to suppress lung metastasis in an experimental metastasis animal model. This miR-145-mediated suppression of cell invasion is in part due to the silencing of the metastasis gene mucin 1 (MUC1). Using luciferase reporters carrying the 3'-untranslated region of MUC1 combined with Western blot and immunofluorescence staining, we identify MUC1 as a direct target of miR-145. Moreover, ectopic expression of MUC1 enhances cell invasion, which can be blocked by miR-145. Of interest, suppression of MUC1 by miR-145 causes a reduction of beta-catenin as well as the oncogenic cadherin 11. Finally, suppression of MUC1 by RNAi mimics the miR-145 action in suppression of invasion, which is associated with downregulation of beta-catenin and cadherin 11. Taken together, these results suggest that as a tumor suppressor, miR-145 inhibits not only tumor growth but also cell invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19996288      PMCID: PMC2805032          DOI: 10.1158/0008-5472.CAN-09-2021

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  Hypoxia enhances MUC1 expression in a lung adenocarcinoma cell line.

Authors:  Yuji Mikami; Akinori Hisatsune; Tomomi Tashiro; Yoichiro Isohama; Hiroshi Katsuki
Journal:  Biochem Biophys Res Commun       Date:  2009-01-12       Impact factor: 3.575

2.  Diagnostic and prognostic microRNAs in stage II colon cancer.

Authors:  Troels Schepeler; Jørgen T Reinert; Marie S Ostenfeld; Lise L Christensen; Asli N Silahtaroglu; Lars Dyrskjøt; Carsten Wiuf; Frank J Sørensen; Mogens Kruhøffer; Søren Laurberg; Sakari Kauppinen; Torben F Ørntoft; Claus L Andersen
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

3.  Cadherin-11 promotes the metastasis of prostate cancer cells to bone.

Authors:  Khoi Chu; Chien-Jui Cheng; Xiangcang Ye; Yu-Chen Lee; Amado J Zurita; Dung-Tsa Chen; Li-Yuan Yu-Lee; Sui Zhang; Edward T Yeh; Mickey C-T Hu; Christopher J Logothetis; Sue-Hwa Lin
Journal:  Mol Cancer Res       Date:  2008-08       Impact factor: 5.852

Review 4.  Structure and function of the polymeric mucins in airways mucus.

Authors:  David J Thornton; Karine Rousseau; Michael A McGuckin
Journal:  Annu Rev Physiol       Date:  2008       Impact factor: 19.318

Review 5.  MicroRNAs--the micro steering wheel of tumour metastases.

Authors:  Milena S Nicoloso; Riccardo Spizzo; Masayoshi Shimizu; Simona Rossi; George A Calin
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

6.  p53 represses c-Myc through induction of the tumor suppressor miR-145.

Authors:  Mohit Sachdeva; Shoumin Zhu; Fangting Wu; Hailong Wu; Vijay Walia; Sumit Kumar; Randolph Elble; Kounosuke Watabe; Yin-Yuan Mo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

Review 7.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

8.  Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.

Authors:  Lorenzo F Sempere; Mette Christensen; Asli Silahtaroglu; Mads Bak; Catherine V Heath; Gary Schwartz; Wendy Wells; Sakari Kauppinen; Charles N Cole
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

9.  miR-145 and miR-143 regulate smooth muscle cell fate and plasticity.

Authors:  Kimberly R Cordes; Neil T Sheehy; Mark P White; Emily C Berry; Sarah U Morton; Alecia N Muth; Ting-Hein Lee; Joseph M Miano; Kathryn N Ivey; Deepak Srivastava
Journal:  Nature       Date:  2009-07-05       Impact factor: 49.962

10.  The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster.

Authors:  Tao Yu; Xiao-yi Wang; Ren-guo Gong; An Li; Sen Yang; Yu-tang Cao; Yu-ming Wen; Chang-mei Wang; Xin-zhu Yi
Journal:  J Exp Clin Cancer Res       Date:  2009-05-13
View more
  163 in total

Review 1.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

Review 2.  Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.

Authors:  Partha Mukhopadhyay; Subhankar Chakraborty; Moorthy P Ponnusamy; Imayavaramban Lakshmanan; Maneesh Jain; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2011-01-26

Review 3.  Implication of microRNAs in drug resistance for designing novel cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong; Shadan Ali
Journal:  Drug Resist Updat       Date:  2010-03-17       Impact factor: 18.500

4.  MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.

Authors:  Chao Zou; Qing Xu; Feng Mao; Dan Li; Chuanxiu Bian; Ling-Zhi Liu; Yue Jiang; Xiaona Chen; Yanting Qi; Xiaolong Zhang; Xuejing Wang; Qiang Sun; Hsiang-Fu Kung; Marie C Lin; Andreas Dress; Fiona Wardle; Bing-Hua Jiang; Lihui Lai
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

5.  Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response.

Authors:  Jiao Wang; Shuangshuang Zheng; Ning Xin; Changxin Dou; Linlin Fu; Xiuying Zhang; Jing Chen; Yanyan Zhang; Deqin Geng; Chenghua Xiao; Guiyun Cui; Xia Shen; Yang Lu; Jinhua Wang; Ruiguo Dong; Yuehua Qiao; Yong Zhang
Journal:  J Neuroimmune Pharmacol       Date:  2013-09-17       Impact factor: 4.147

6.  miR-145: Revival of a Dragon in Pancreatic Cancer.

Authors:  Saini Setua; Sheema Khan; Kyle Doxtater; Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  J Nat Sci       Date:  2017-03

7.  Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer.

Authors:  Rui-Lei Liu; Ye Dong; Yan-Zhen Deng; Wen-Jun Wang; Wei-Dong Li
Journal:  Tumour Biol       Date:  2015-04-27

8.  miR-214 targets ATF4 to inhibit bone formation.

Authors:  Xiaogang Wang; Baosheng Guo; Qi Li; Jiang Peng; Zhijun Yang; Aiyuan Wang; Dong Li; Zhibo Hou; Ke Lv; Guanghan Kan; Hongqing Cao; Heng Wu; Jinping Song; Xiaohua Pan; Qiao Sun; Shukuan Ling; Yuheng Li; Mu Zhu; Pengfei Zhang; Songlin Peng; Xiaoqing Xie; Tao Tang; An Hong; Zhaoxiang Bian; Yanqiang Bai; Aiping Lu; Yinghui Li; Fuchu He; Ge Zhang; Yingxian Li
Journal:  Nat Med       Date:  2012-12-09       Impact factor: 53.440

9.  miR-145 regulates myofibroblast differentiation and lung fibrosis.

Authors:  Shanzhong Yang; Huachun Cui; Na Xie; Mert Icyuz; Sami Banerjee; Veena B Antony; Edward Abraham; Victor J Thannickal; Gang Liu
Journal:  FASEB J       Date:  2013-03-01       Impact factor: 5.191

Review 10.  DNA methylation and microRNA dysregulation in cancer.

Authors:  Hiromu Suzuki; Reo Maruyama; Eiichiro Yamamoto; Masahiro Kai
Journal:  Mol Oncol       Date:  2012-08-10       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.